Compounds > mk 0663

Page last updated: 2024-09-03

mk 0663 and Dermatitis Medicamentosa

mk 0663 has been researched along with Dermatitis Medicamentosa in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (29.41)	29.6817
2010's	9 (52.94)	24.3611
2020's	3 (17.65)	2.80

Authors

Authors	Studies
Bellón, T; Cabañas, R; Domínguez-Ortega, J; Fiandor, A; González-Muñoz, M; Hakobyan, A; Marques-Mejias, MA; Movsisyan, M; Quirce, S	1
Galán Gimeno, C; Gamboa Setién, PM; Jáuregui Presa, I; Martínez Antón, MD; Sánchez de Vicente, J	1
Bates, TJ; Brown, RM; Perks, A; Poveda-Gallego, A; Velangi, S	1
Belver, MT; Blanco, C; Freih, A; Múgica, MV; Vega, F; Vera, A	1
Cantero Macedo, AM; Palmerín-Donoso, A; Tejero-Mas, M	1
Amaro, C; Ferreira, ML; Miroux-Catarino, A; Silva, L; Viana, I	1
Caro Gutiérrez, D; Gómez de la Fuente, E; López Estebaranz, JL; Pampín Franco, A	1
Caralli, ME; De Barrio Fernández, M; Pelta Fernández, R; Rojas Pérez-Ezquerra, P; Seoane Rodríguez, M	1
Avila, R; Cimbollek, S; Quiralte, J	1
Azevedo, F; Calistru, AM; Cunha, AP; Nogueira, A	1
Andrade, P; Gonçalo, M	1
Dávila, I; González, A; Laffond, E; Moreno, E; Muñoz-Bellido, F; Ponce, V	1
Becker, A; Dömkes, S; Hillen, U; Livingstone, E; Schadendorf, D; Zimmer, L	1
Colanardi, MC; Ferrannini, A; Nettis, E; Tursi, A; Vacca, A	1
Asero, R	1
Nikkels, AF; Piérard, GE; Thirion, L	1
Lammintausta, K; Mäkelä, L	1

Trials

3 trial(s) available for mk 0663 and Dermatitis Medicamentosa

Article	Year
Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management. Archives of dermatology, 2012, Volume: 148, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthralgia; Disease Progression; Dose-Response Relationship, Drug; Drug Eruptions; Etoricoxib; Female; Humans; Imidazoles; Indoles; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Staging; Oximes; Panniculitis; Point Mutation; Proto-Oncogene Proteins B-raf; Pyridines; Skin Neoplasms; Sulfonamides; Sulfones; Vemurafenib	2012
Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2005, Volume: 95, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Demography; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Middle Aged; Patients; Pyridines; Single-Blind Method; Sulfones	2005
Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. Clinical and experimental dermatology, 2007, Volume: 32, Issue:6 Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Eruptions; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines; Single-Blind Method; Sulfonamides; Sulfones; Tramadol; Urticaria	2007

Other Studies

14 other study(ies) available for mk 0663 and Dermatitis Medicamentosa

Article	Year
The Lymphocyte Transformation Test Is Useful in the Diagnosis of Fixed Drug Eruption Induced by Etoricoxib. Journal of investigational allergology & clinical immunology, 2019, Volume: 29, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Etoricoxib; Female; Humans; Lymphocyte Activation; Lymphocytes; Middle Aged	2019
Etoricoxib-induced fixed drug eruption: Report of seven cases. Contact dermatitis, 2021, Volume: 84, Issue:3 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Dermatitis, Allergic Contact; Drug Eruptions; Etoricoxib; Female; Humans; Male; Middle Aged; Patch Tests	2021
Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report. Oral surgery, oral medicine, oral pathology and oral radiology, 2021, Volume: 131, Issue:4 Topics: Drug Eruptions; Etoricoxib; Humans; Mouth Mucosa; Patch Tests; Skin	2021
Neutrophilic Generalized Fixed Drug Eruption Induced by Etoricoxib. Journal of investigational allergology & clinical immunology, 2021, Dec-21, Volume: 31, Issue:6 Topics: Drug Eruptions; Etoricoxib; Humans; Patch Tests	2021
[Fixed drug eruption induced by etoricoxib]. Atencion primaria, 2019, Volume: 51, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Etoricoxib; Humans; Male	2019
Bullous fixed drug eruption induced by etoricoxib, confirmed by patch testing, with tolerance to celecoxib. Contact dermatitis, 2019, Volume: 81, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Blister; Celecoxib; Drug Eruptions; Etoricoxib; Female; Humans; Middle Aged; Patch Tests	2019
Fixed drug eruption due to etoricoxib in a patient with tolerance to celecoxib: the value of patch testing. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:3 Topics: Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etoricoxib; Female; Humans; Patch Tests; Pyrazoles; Pyridines; Sulfonamides; Sulfones	2014
Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib. Journal of investigational allergology & clinical immunology, 2016, Volume: 26, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Drug Eruptions; Etoricoxib; Exanthema; Female; Humans; Middle Aged; Osteoarthritis; Patch Tests; Pyridines; Sulfones	2016
COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs. The New England journal of medicine, 2009, Nov-26, Volume: 361, Issue:22 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Female; Humans; Male; Pyrazoles; Pyridines; Sulfonamides; Sulfones	2009
Etoricoxib-induced fixed drug eruption with positive lesional patch tests. Cutaneous and ocular toxicology, 2011, Volume: 30, Issue:2 Topics: Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etoricoxib; Female; Humans; Middle Aged; Patch Tests; Pyridines; Skin; Sulfones	2011
Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing. Contact dermatitis, 2011, Volume: 64, Issue:2 Topics: Aged; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etoricoxib; Female; Humans; Middle Aged; Patch Tests; Pyridines; Sulfones	2011
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib. Contact dermatitis, 2012, Volume: 66, Issue:2 Topics: Aged; Arm; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Etoricoxib; Female; Humans; Isoxazoles; Leg Dermatoses; Low Back Pain; Patch Tests; Pyrazoles; Pyridines; Sulfonamides; Sulfones	2012
Etoricoxib-induced erythema-multiforme-like eruption. Dermatology (Basel, Switzerland), 2008, Volume: 216, Issue:3 Topics: Aged; Arthritis; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Erythema Multiforme; Etoricoxib; Humans; Male; Pyridines; Skin; Sulfones	2008
Etoricoxib-induced acute generalized exanthematous pustulosis. Acta dermato-venereologica, 2008, Volume: 88, Issue:2 Topics: Acute Disease; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Exanthema; Humans; Male; Middle Aged; Patch Tests; Pyridines; Skin; Skin Diseases, Vesiculobullous; Sulfones	2008